Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Argentina sets up national cancer institute

This article was originally published in RAJ Devices

Executive Summary

Argentina's health ministry has created a National Institute of Cancer aimed at research activities related to the prevention, diagnosis and treatment of cancer1. Among other things, the new institute will support and co-ordinate research projects carried out by universities, hospitals, foundations and companies. It will also conduct basic and clinical research in its own laboratories and clinics.

You may also be interested in...



Argentina sets out rules for switching from prescription to OTC status

ANMAT, Argentina's drug and healthcare products regulatory agency, has issued a regulation establishing the minimum requirements that companies need to follow in order to switch their product from prescription-only to over-the-counter status1.

Argentina's ANMAT launches new regulatory strategy

Argentina's National Medicines, Food and Medical Technology Administration, ANMAT, has developed a new strategy to generate timely national and international information about the products and processes within its remit, so that the regulator can identify problems affecting public health and propose appropriate actions1.

Argentina targets tropical diseases, cancer

Argentina's Ministry of Health has recently stepped up its efforts to combat tropical diseases and cancer.

UsernamePublicRestriction

Register

SC096338

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel